Enanta Pharmaceuticals Inc (ENTA): 1 insider purchase in the last two years (1 opportunistic); 1 trade disclosed by members of Congress.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Feb 12, 2025 | Luly Jay R. Director, Officer | 45,000 | $5.69 | $256.1K | opportunistic |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.
| Filed | Member | Type | Amount |
|---|---|---|---|
| Aug 13, 2023 | Daniel Goldman | sale | $1,001 - $15,000 |